Addex Therapeutics Ltd ADXN

$ 7.38 -0.67%

Annual report 2023
added 11-09-2024

Addex Therapeutics Ltd Financial Statements 2011-2024 | ADXN

Annual Financial Statements Addex Therapeutics Ltd

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	196 M	47.4 M	24 M	-	-	-	-	-	-	-	-
Shares	-	-	34.1 M	4.4 M	4.4 M	-	-	-	-	-	-	-	-
Historical Prices	16.1	0.52	5.73	10.8	-	-	-	-	-	-	-	-	-
Net Income	-	-	-15.4 M	-12.9 M	-14.8 M	-1.64 M	-3.28 M	-3.15 M	-4.2 M	-1.77 M	-14.5 M	-27 M	-31.1 M
Revenue	-	-	-	3.61 M	2.76 M	6.04 M	-	-	-	-	-	-	2.82 M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	2.53 M	5.9 M	-29.8 K	-	-	-	-	-1.27 M	-25.2 M
Operating Income	-	-	-15.5 M	-12.2 M	-14.6 M	-1.42 M	-3.24 M	-	-	-	-	-	-
Interest Expense	1.64 K	25.9 K	39.1 K	50.5 K	106 K	134 K	171	-	-	-	-	-	-
EBITDA	-	-	-15.5 M	-12.2 M	-14.6 M	-1.42 M	-3.24 M	-3.12 M	-2.61 M	-1.71 M	-13.8 M	-24.9 M	-28 M
Operating Expenses	11.9 M	22 M	18.7 M	16.1 M	17.4 M	8.13 M	3.73 M	-	-	-	-	25.7 M	5.81 M
General and Administrative Expenses	-	-	5.82 M	5.15 M	4.92 M	4.72 M	2.2 M	1.52 M	1.57 M	1.55 M	6.47 M	12.9 M	6.73 M

All numbers in CHF currency

Quarterly Income Statement Addex Therapeutics Ltd

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CHF currency